News
Natoli Engineering's Precision CT Scan allows manufacturers to visualize internal tablet structures without cutting or ...
Körber’s Business Area Pharma now offers a standardized approach to connect systems and equipment to its market-leading PAS-X ...
Almac Clinical Services has completed a multi-million-dollar investment to enhance cold chain capabilities at its global ...
Circio Holding ASA, a biotechnology company developing circular RNA technology for next generation nucleic acid medicine, has ...
Pace Life Sciences LLC is remodeling and expanding its Salem, NH, site to establish a Center of Excellence for Aseptic ...
The CDMO has increased its capacity by acquiring and installing a new, fully Annex 1 compliant, sterile filling line. As a ...
Axplora has announced a transformative €35 million ($41.2 million) expansion at its Farmabios site in Gropello Cairoli, Italy ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Fujifilm’s FF-10832, an investigational liposomal formulation of gemcitabine, for the treatment of biliary tract ...
Biosynth, a developer and supplier of critical raw materials and services for life sciences and diagnostics, has opened an expanded GMP bioconjugation facility at its existing Berlin site.
The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...
Hikma Pharmaceuticals will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities.
It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results